[1] [1] SHAYKH F S A, CRAMER M T. Uric acid and the kidney［J］. Pediatric Nephrology, 2014, 29(6): 999-1008.

[2] [2] WENG Xiaolu, LIN Sundong, NI Yongqing, et al. Fibroblast growth factor 21 attenuates diabetes-induced renal fibrosis by inhibiting EMT［J］. Journal of Medical Research, 2019, 48(6): 35-41.

[3] [3] RODENBACH K E, SCHNEIDER M F, FURTH S L, et al. Hy- peruricemia and progression of CKD in children and adolescents: the chronic kidney disease in children (CKiD) cohort study［J］. American Journal of Kidney Diseases, 2015, 66(6): 984-992.

[4] [4] HSIA S H, CHOU I J, KUO C F, et al. Survival impact of serum uric acid levels in children and adolescents［J］. Rheumatology International, 2013, 33( 11): 2797-2802.

[5] [5] YAN Q, LUO H, WANG BY, et al. Correlation between PKB/Akt, GSK-3beta expression and tubular epithelial-mesenchymal transi- tion in renal allografts with chronic active antibody-mediated re- jection［J］. Experimental and Therapeutic Medicine, 2017, 13(5): 2217-2224.

[6] [6] MARCHENA M, ZORI B V, DIEZ J Z, et al. Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa［J］. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017, 32( 1): 522-526.

[7] [7] YAN Qiang, JIANG Hua, SUI Weiguo, et al. Expression and sig- nificance of GSK-3β and NF-κB in renal tissue with chronic active antibody-mediated rejection［J］. Chinese Journal of Nephrology, Dialysis & Transplantation, 2013, 22(5): 415-421.

[8] [8] LARCO J E D, TODARO G J. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation［J］. Journal of Cellular Physiology, 1978, 94(3): 355-342.

[9] [9] REN L, FANG L, ZIYANG D, et al. Estradiol ameliorates acute kidney ischemia-reperfusion injury by inhibiting the TGF-βRI- SMAD pathway［J］. Frontiers in Immunology, 2022, 13(2): 822.

[10] [10] ZENG Yupeng, XIE Xisheng. Effects and mechanism of uric acid on proliferation and apoptosis of renal tubular epithelial cells［J］. The Journal of Practical Medicine, 2018, 34(24): 4042-4045.

[11] [11] YANG Jie, LIU Liwentao, CHEN Bingpu, et al. Exploring the correlation between blood uric acid and ZAG based on a mouse model of hyperuricemia［J］. Journal of Youjiang Medical Univer- sity for Nationalities, 2017, 39( 1): 26-28.

[12] [12] TAO M, SHI Y F, TANG L X, et al. Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy［J］. American Journal of Physiology Renal Physiology, 2019, 316(4): F660-F673.

[13] [13] YAN Zhe, JIAO Sumin, YANG Lin, et al. Expression of zinc-u2- glycoprotein in patients with diabetic nephropathy and its relation- ship with clinicopathological parameters［J］. Journal of Hebei Medical University, 2019, 40( 11): 1251-1254, 1274.

[14] [14] PELLETIER C C, KOPPE L, CROZE M L, et al. White adipose tissue overproduces the lipid-mobilizing factor zinc alpha2-glyco- protein in chronic kidney disease［J］. Kidney International, 2013, 83(5): 878-886.

[15] [15] CHEN W L, LIN C T, LI J W, et al. ERK1/2 activation regulates the wound healing process of rabbit corneal endothelial cells［J］. Current Eye Research, 2009, 34(2): 103-111.

[16] [16] HUH J E, NAM D W, BAEK Y H, et al. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways［J］. International Immunopharmacology, 2011, 11( 1): 46-54.

[17] [17] LIU C M, SUN Y Z, SUN J M, et al. Protective role of quercetin against lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF-kappaB pathway［J］. Biochi- mica et Biophysica Acta, 2012, 1820( 10): 1693-1703.

[18] [18] ZHUANG Y B , FENG Q C , DING G X , et al. Activation of ERK1/2 by NADPH oxidase-originated reactive oxygen spe- cies mediates uric acid-induced mesangial cell proliferation［J］. American Journal of Physiology. Renal Physiology, 2014, 307(4): F396-F406.

[19] [19] TOSU A R, DEMIR S, SELCUK M, et al. Comparison of inflam- matory markers in non-dipper hypertension vs. dipper hyperten- sion and in normotensive individuals: uric acid, C-reactive protein and red blood cell distribution width readings［J］. Postepy Kardiol Interwencyjnej, 2014, 10(2): 98-103.

[20] [20] BAAN B, ZON G C M V D, MAASSEN J A, et al. The nuclear appearance of ERK1/2 and p38 determines the sequential induc- tion of ATF2-Thr71 and ATF2-Thr69 phosphorylation by serum in JNK-deficient cells［J］. Molecular and Cellular Endocrinology, 2009, 311( 1/2): 94-100.